Stealth BioTherapeutics Inc. announced the appointment of three directors to its Board of Directors: Francis W. Chen, Kevin McLaughlin and Edward Owens. Stealth's Board of Directors now includes five members with extensive experience in biotechnology and business development. Francis W. Chen is a co-founder and board member of SinoAmerican Partners Limited. Dr. Chen was formerly Vice Chairman at WI Harper Group and has over twenty years of senior management experience in the healthcare industry at Becton-Dickinson, Baxter Healthcare, Hygeia Sciences/Tambrands and Scotgen Biopharmaceuticals. He served as a trustee of the Burnham Institute, Groton School, San Francisco Opera Association and Stein Eriksen Lodge Owners' Association. Kevin McLaughlin has been the Senior Vice President, Chief Financial Officer and Treasurer of Acceleron Pharma Inc. since 2010. Previously, Mr. McLaughlin served as Senior Vice President and Chief Financial Officer of Qteros Inc. In 2007, he co-founded Aptius Education Inc. where he served as the Chief Operating Officer and member of the Board of Directors. Prior to Aptius, Mr. McLaughlin spent 10 years at PRAECIS Pharmaceuticals Inc., ultimately as President, CEO and a member of the Board of Directors. Edward Owens is a retired Partner of Wellington Management Company LLP, where he worked for 38 years as a portfolio manager and global industry analyst. He was the founding portfolio manager of Vanguard Health Care Fund, which he managed from 1983 until his retirement at the end of 2012.